A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478
Clinical trial NCT04452006 · TERMINATED
Trial details
- NCT number
- NCT04452006
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-04-20
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.